Skip to content

Effects of gut leakage on microbiome homeostasis and systemic immunity in dengue patients

Effects of gut leakage on microbiome homeostasis and systemic immunity in dengue patients

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
TCTR
Registry ID
TCTR20240625002
Enrollment
120
Registered
2024-06-25
Start date
2024-06-24
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dengue infection patients and healthy volunteers who are 18-50 years old. gut leakage microbiome homeostasis systemic immunity dengue

Interventions

Participants diagnosed with dengue infection (by dengue antigen NS1 or PCR) with or without warning signs, or severe dengue, and in-hospitalization.,No previously diagnosed dengue fever (by taking his
Diagnostic,Diagnostic
Dengue patient group,Healthy volunteer group

Sponsors

The e-ASIA Joint Research Program; PMU-B
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 50 Years

Inclusion criteria

Inclusion criteria: 1. Dengue patient group 1.1 Participants diagnosed with dengue infection (by dengue antigen NS1 or PCR) with or without warning signs, or severe dengue, and in-hospitalization. 1.2 Able to provide written informed consent. 2. Healthy volunteer group 2.1 No previously diagnosed dengue fever (by taking history) within five years. 2.2 Able to provide written informed consent.

Exclusion criteria

Exclusion criteria: 1. Presence of severe comorbidities (e.g. severe pneumonia, co-infection of either local or systemic infections, active cardiovascular or cerebrovascular, active malignancy) at time of admission. 2. Recent use of antibiotic or prebiotic and/or probiotics 3. History of gastrointestinal surgery 4. Pregnancy 5. Non-Thai language speaking participants

Design outcomes

Primary

MeasureTime frame
Characterization of fecal microbiota Two separate days during in-hospitalization and one time-point collection for healthy volunteers High-throughput DNA sequencing

Secondary

MeasureTime frame
Exosome identification At the enrollment and another collected on day 7 of onset RT-qPCR for microRNAs,Gut permeability At the enrollment and another collected on day 7 of onset Serum concentration of human zonolin; serum calprotectin; serum beta-D-glucan; serum occludin; serum TJP1; serum lipopolysaccharide,Cell-free bacterial DNA At the enrollment and another collected on day 7 of onset Fluorescence-based assay,Neutrophil extracellular traps and low-density granulocytes At the enrollment and another collected on day 7 of onset Isolation PBMC and PMN for NETs and LDGs detection

Countries

Thailand

Contacts

Public ContactWiwat Chancharoenthana

Mahidol University

wiwat.cha@mahidol.ac.th023549168

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026